1. Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain

   • Yi Zheng
   • Xijing Chen
   • Leslie Z. Benet

   Review Article 21 August 2015 Pages: 143 - 167

   

2. Alternative Sampling Strategies for Cytochrome P450 Phenotyping

   • Pieter M. M. De Kesel
   • Willy E. Lambert
   • Christophe P. Stove

   Review Article 04 August 2015 Pages: 169 - 184

3. Challenges Associated with Route of Administration in Neonatal Drug Delivery

   • Matthew W. Linakis
   • Jessica K. Roberts
   • Catherine M. T. Sherwin

   Review Article 06 August 2015 Pages: 185 - 196

4. Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

   • Sivi Ouwerkerk-Mahadevan
   • Jan Snoeys
   • Alexandru Simion

   Review Article Open access 09 September 2015 Pages: 197 - 208

5. Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus

   • Eef Hoeben
   • Willem De Winter
   • Adrian Dunne

   Original Research Article 21 August 2015 Pages: 209 - 223

   

6. Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants

   • Ivo P. Nnane
   • Alexei H. Plotnikov
   • Brian E. Davies

   Original Research Article 05 August 2015 Pages: 225 - 236

   

7. Effects of Cytochrome P450 3A4 Inhibitors—Ketoconazole and Erythromycin—on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions

   • Christophe Boetsch
   • Neil Parrott
   • Carsten Hofmann

   Original Research Article 04 September 2015 Pages: 237 - 247

   

8. Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch

   • Lisette Binkhorst
   • Marjolein Bannink
   • Ron H. J. Mathijssen

   Original Research Article Open access 08 October 2015 Pages: 249 - 255